Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2/3 Study of Dose-escalated External Beam Radiation Therapy

NCT01811810 is registered in ClinicalTrials.gov with Abramson Cancer Center at Penn Medicine as lead sponsor.

NCT NCT01811810
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01811810 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2/3 Study of Dose-escalated External Beam Radiation Therapy
Lead sponsor
Abramson Cancer Center at Penn Medicine
Phase
Not applicable
Overall status
Withdrawn
Start date
March 31, 2013
Completion date
April 30, 2014
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer